(Q44867991)

7 December 2017

title

Pharmacokinetics of flunixin meglumine in swine after intravenous dosing (English)

1 reference

7 December 2017

1 reference

Buur JL

1

1 reference

7 December 2017

Baynes RE

series ordinal

2

1 reference

7 December 2017

Smith G

series ordinal

3

1 reference

7 December 2017

Riviere JE

series ordinal

4

1 reference

7 December 2017

publication date

1 October 2006

1 reference

Journal of Veterinary Pharmacology and Therapeutics

7 December 2017

published in

1 reference

7 December 2017

volume

29

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

437-440

1 reference

Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Pharmacokinetics of etoricoxib in patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Disposition of sodium salicylate, flunixin and meloxicam after intravenous administration in broiler chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Pharmacokinetics of flunixin meglumine in llamas following a single intravenous dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Pharmacokinetic interactions of flunixin meglumine and enrofloxacin in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Disposition of flunixin meglumine injectable preparation administered orally to healthy horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2006.00788.X

10.1111/J.1365-2885.2006.00788.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference